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Abstract Solanum nigrum, a medicinal plant, tradition-
ally used in treating diabetes mellitus. In this study, we
used the leaf extract of the plant to synthesize silver
nanoparticles (AgNPs), as a proposition to treat alloxan-
induced diabetic rats. The phytosynthesised AgNPs were
analyzed using UV–visible and Fourier transform infra-red
spectroscopy for their functional groups. Transmission
electron microscopy revealed that, the synthesized particles
are found to be 4–25 nm in size. Monodispersed and
spherical nature of synthesized AgNPs were shown by
scanning electron microscope and the presence of Ag in the
AgNPs was confirmed by energy dispersive spectrum. The
phytosynthesised AgNPs were evaluated for its antidiabetic
activity in alloxan-induced diabetic rats. AgNPs-treated
diabetic rats found to be significantly improved the dys-
lipidemic condition as seen in the diabetic control. Fur-
thermore, it also reduced the blood glucose level over the
period of treatment. The improvement in body weight was
also found to be evidence for S. nigrum extract-mediated
AgNPs as a potential antidiabetic agent against alloxan-
induced diabetic rats.
Keywords Diabetes mellitus  Solanum nigrum  Silver
nanoparticles  Alloxan  Animal model
Introduction
Diabetes mellitus (DM) is a group of syndromes charac-
terized by hyperglycemia; altered metabolism of lipids,
carbohydrates, and proteins; and an increased risk of
complications from vascular disease that affects 10 % of
the population [1, 2]. Despite, the availability and exten-
sive utilization of hypoglycemic agents, diabetes and the
related complications continue to be major health con-
cerned worldwide [3]. According to International Diabetic
Federation the estimated diabetes prevalence in 2010 has
risen to 285 million, representing 6.4 % of the world’s
adult population, with a prediction that by 2030, the
number of people with diabetes will have risen to 438
million, with this alarming concern, India has been
declared as the ‘‘Diabetic capital of world’’. Currently 40.9
million people in India suffering from diabetes and by 2030
there would be 79.44 million diabetics in India alone. It is
also estimated that by the year 2030, diabetes is likely to be
the seventh leading cause of death, accounting 3.3 % of
total deaths in the world [4].
Owing to the progressive nature of the disease, an
improved treatment strategy is required, which includes,
the discovery of new drugs [5]. In addition, drug treatment,
is not completely successful with diabetes and there is a
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strategies [6]. Nevertheless, traditionally people have been
using many plants to treat diabetes empirically despite the
lack of safety and efficacy [7]. At this juncture, it is nec-
essary to test the herbal medicine as an alternative to
synthetic agent [8].
In the search of new opportunities for treatment of DM,
the current study has focused on the efficacy of S. nigrum.
The plants belong to the Solanaceae family, are considered
as poisonous to human, however, S. nigrum is an edible
plant and possesses antioxidant and hepatoprotective
activity [9]. Furthermore, many parts of this plant are used
as a traditional medicine. Despite, it has been used as an
antidiabetic agent in traditional medicine, it lacks scientific
evidence [10]. In addition, this is the first of its kind
reporting the efficiency of S. nigrum-mediated AgNPS as
an anti-hyperglycemic agent.
Since, the last decade the applications of AgNPs have
been increasing rapidly in various fields. Originally, the
silver metal was used as an anti-microbial agent, later in
the 1990’s it has been used in the medicinal field as silver
colloids to treat various diseases [11]. AgNPs are usually a
cluster of particles ranging between 1 and 100 nm in size
and they exhibit new properties based on their size, dis-
tribution and morphology [12]. Nanoparticles are becom-
ing the focus of intensive research, due to their wide range
of applications in areas such as catalysis, optics, antimi-
crobials, and biomaterial production [13, 14].
Various approaches have been used for the synthesis of
AgNPs. The phytosynthesis approach has many advantages
over chemical, physical, and microbial synthesis [15–18],
as there is no need of the elaborated process of culturing
and maintaining the cell, hazardous chemicals and high-
energy requirements.
In the present study, we have characterized the S.
nigrum leaf extract-mediated AgNPs and assessed it, as an
antidiabetic agent in alloxan-induced diabetic rat model.
Materials and methods
Collection of plants
The S. nigrum plant material was collected from Erode
District, Tamil Nadu, India and authenticated by Dr.
S. ArunPrakash, Department of Botany, Government Arts
College, Namakkal, Tamil Nadu, India.
Preparation of aqueous extract
The leaves of the plants collected were washed and air
dried in shade at room temperature for 7 days. The air
dried plants were pulverized in an electric grinder and
sieved using mesh to obtain uniform size for further study.
The extraction process was carried out with the help of
Soxhlet apparatus. Fifteen grams of dry powder were
subjected to soxhlet extraction with 300 mL methanol, the
extraction was repeated up to 10 cycles at 45 C to ensure
the complete recovery.
Synthesis of AgNPs
AgNPs synthesis was carried out according to Aravinthan
et al. [19]. Briefly, 4 mL of the aqueous extract was mixed
with 96 mL of 1 mM AgNO3 solution and the resulting
greenish white mixture was incubated for 8 h in a rotary
shaker (200 rpm) at 26 C. Reduction of Ag? ions to Ag
nanocrystals was monitored by a change in color of the
reaction mixture from greenish white to dark brown [19].
Characterization of AgNPs
Surface Plasmon resonance (SPR) bands of the synthesized
AgNPs were characterized using UV–Vis spectroscopy
(Shimadzu UV-2450) in the range of 200–600 nm. Mor-
phological analysis and the crystalline nature of the parti-
cles were investigated by transmission electron microscopy
(TEM) using FEI Tecnai TF 20 high-resolution TEM
instrument operated at an accelerating voltage of 200 kV
[20]. The characterization of the synthesized AgNPs was
conducted with X-ray diffractometer (XPERT-Pro
diffractometer using Cu Ka radiation), operated at 2h from
30 to 80 at 0.041/min with a time constant of 2 s. AgNPs
synthesis and the elemental composition were further
confirmed by SEM–EDS (SEM–EDS; JEOL-64000,
Japan). The chemical characterization of changes in the
surface and surface composition was performed by Fourier
transform infrared spectroscopy (Shimadzu) within the mid
IR region of frequency 4000–400 cm-1 [19].
Induction of diabetes
Diabetes was induced in male Wistar albino rats aged more
than 8 weeks (140–160 g body weight) by single
intraperitoneal administration of alloxan (single dose of
200 mg/kg body weight). Within 48 h after alloxan
administration, blood glucose concentrations were mea-
sured via tail clip sampling. Animals with a blood glucose
concentration 200 mg/dL were considered to be diabetic
[21].
Toxicity assessment in rat
Acute toxicity test on AgNPs was performed in experi-
mental rats with a graded dose levels of AgNPs (10 and
20 mg/kg body weight) [22]. The rats were observed
continuously for 2 h for behavioral, neurological and
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autonomic profiles and after a period of 24 and 72 h for any
lethality or death. Further experiments were carried out
using 10 mg/kg body weight AgNPs.
Experimental design
The animals were divided into five groups and each group
consisted of 5 rats. Group I: Untreated normal rats; (Nor-
mal control, received only distilled water) Group II: Dia-
betic control, alloxan 200 mg/kg single dose, received no
treatment; Group III: Diabetic rats, received glibenclamide
0.5 mg/kg for 21 days; Group IV: Diabetic rats, received S.
nigrum Methanol extract 10 mg/kg for 21 days; Group V:
Diabetic rats, received phytosynthesised AgNPs 10 mg/kg
for 21 days.
Oral glucose tolerance test
The oral glucose tolerance test was performed after
21 days administration of AgNPs and plant extract to the
respective groups. The rats were fasted overnight, and 2 g/
kg glucose was administered orally and the blood was
collected from the tail vein prior and the post administra-
tion of glucose at 0,30,60,90, and 120 min and fasting
blood glucose level was measured using a glucometer
(Accu-Chek, Roche Diagnostic, Manheim, Germany).
Biochemical analysis
Blood samples were collected by retro orbital puncture and
centrifuged at 10009g for 15 min and the collected serum
was stored at -80 C until analysis. Total cholesterol and
Triglycerides were estimated using (Biovision, Milpitas,
CA, USA) kit as manufacture’s instruction.
Statistical analysis
All the data were expressed as mean ± SD, and the sta-
tistical significance between the groups was analyzed using
one-way ANOVA followed by Tukey’s post hoc test. If
P B 0.05 were considered significant.
Results and discussion
Synthesis and characterization of AgNPs
The S. nigrum leaf extract was mixed in the aqueous
solution of the silver ion complex, and became yellowish
brown due to the reduction of silver ion, indicating the
completion of the reaction. Similar changes in color have
also been reported earlier [23, 24]. The AgNps exhibit
yellowish brown color in aqueous solution owing to exci-
tation of surface plasmon vibrations in AgNPs [25, 26].
The plant leaf extract known to posses many active com-
pounds such as, sugar [27] caffeine and theophylline [28]
and antioxidants [29] are reported to involve in the for-
mation of AgNPs. As S. nigrum also contains high
antioxidants, we speculate this AgNPs formation due to the
presence of high amount of antioxidants in the extract [9].
The Fig. 1a represents the absorbance spectrum of AgNPs
formed at various times (0, 2, 4, 6 h) and the maximum
absorption peak was observed in the range of 370–420 nm.
It is reported that the absorption spectrum of spherical
AgNPs present at 420 nm, and maximum absorption peak
shift towards the blue region directly correlates with
smaller particle size, and providing the clue for the size of
the synthesized nanoparticle in the range of B25 nm [30].
Figure 1b shows a representative TEM image of phy-
tosynthesized AgNPs. The AgNPs were seen to be spher-
ical and monodispersed with the size range of 4–25 nm.
This result is well agreed with the UV–Vis spectra result, in
which the maximum peak shifts towards the blue region (k
Fig. 1 a UV–visible spectrum of green synthesized AgNPs at
different time intervals, showed peak at 420 nm. b TEM image of
AgNPs
J Nanostruct Chem (2016) 6:41–48 43
123
Fig. 2 a X-ray diffraction for
crystalline nature of S. nigrum
leaf extract-mediated silver
nanoparticles. b SEM EDX
spectrum of AgNPs, after
formation of AgNPs with
different X-ray emission peaks
labeled
Fig. 3 FTIR spectrum of
phytosynthesized AgNPs
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max at 420 nm), and providing the direct evidence for size
[30].
The crystalline nature of the silver nanoparticles of S.
nigrum, the XRD analysis was undertaken, Fig. 2a
revealing six peaks at degree (2h) 10.00, 11.51, 12.00,
27.75, 32.15, and 45.94 corresponding to six diffraction
facets of silver. The broadening of X-ray peaks observed
can be attributed to the organic content of leaf extract.
Analysis of AgNPs through Energy dispersive X-ray
(EDX) spectrometers confirmed the presence of elemental
silver signal at 3 keV along (Fig. 2b) with other weak
signals corresponding to oxygen and carbon, which could
have essentially derived from the plant extract and con-
sistent with previous studies [31, 32]. FTIR measurement
was carried out to identify the possible biomolecules in S.
nigrum leaf extract responsible for capping leading to
efficient stabilization of the silver nanoparticles (Fig. 3).
The IR spectrum of silver nanoparticles manifests promi-
nent absorption bands located at 3282, 2926, 2357, 1670,
1523, 1240, 1064, 667, and 422.41 cm-1. The bands seen
Fig. 4 a Effect of oral
administration of S. nigrum leaf
extract and AgNPs at a dose of
10 mg/kg, in Blood glucose
level of alloxan-induced
diabetic rats before and after
treatment. Each column
represents mean ± SD for five
rats. *P\ 0.05; **P\ 0.01;
***P\ 0.001 different from
diabetic control. b Effect of S.
nigrum leaf extract and AgNPs
in oral glucose tolerance test
after 21 days of treatment. Each
column represents mean ± SD
(n = 5). All the values were
found to be statistically
significant compared to diabetic
control at *P\ 0.05
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in 3282 and 2926 cm-1 represent the stretching vibrations
of primary and secondary amines, respectively. The peak at
2357 could be attributed to H bonded OH stretching of a
secondary metabolites present in the extract which might
act as a reducing agent to synthesize AgNPs [33].
The antidiabetic activity of phytosynthesized AgNPs
An acute toxicity study revealed the non-toxic nature of the
methanolic extract and green synthesized AgNPs. The rats
treated with different doses of S. nigrum did not show any
drug-induced physical signs of toxicity during the whole
experimental period, and no deaths were observed. Based
on the acute toxicity studies, with a varying concentration
(10, 20 mg/kg) of AgNPs, 10 mg/kg body weight was fixed
as an optimal concentration, and thus used in the treatment
of alloxan-induced diabetic rats.
The blood glucose level of each group has been esti-
mated during the course of treatment (Fig. 4a), to evaluate
anti-hyperglycemic effect of plant extract and phytosyn-
thesized AgNPs. At 14 and 21 days the treated groups
(extract/AgNPs) pronouncedly decrease the blood glucose
level compared to that of diabetic control (Group II).
AgNPs were shown to have reduced blood glucose level
higher than plant extract alone. On the other hand gliben-
clamide-treated groups significantly reduced the blood
glucose level throughout the period of treatment compared
to group II, IV and V.
The glucose tolerance level of S. nigrum leaf extract-
mediated AgNPs-treated group was evaluated in diabetic
rats (Fig. 4b), by estimating its efficacy in reducing
hyperglycemic condition in blood followed an adminis-
tration of glucose orally, and compared it with standard
drug (Glibenclamide 0.5 mg/kg). The phytosynthesized
AgNPs-treated animals shown to have a significant
improvement in lowering blood glucose compared to
Group II. Among the treated groups the efficiency of
compounds in lowering the blood glucose level over a
period of 2 h has followed with an order, group III[ group
V[ group IV. Phytosynthesized AgNPs treatment is
shown to improve the blood glucose level which is com-
parable to glibenclamide-treated groups. Alloxan-induced
diabetic rat model has been widely used in several studies
[34, 35]. In addition, the mode of action of alloxan is well
documented [36]. In the treatment of diabetes, blood glu-
cose concentration is considered as a routine and major
biochemical marker to monitor the improvement in the
disease condition, the results obtained for blood glucose
concentration of treated groups showed a smaller total area
Fig. 5 Effect of methanolic extract of S. nigrum and AgNPs on body
weight before and after treatment. Each column represents
mean ± SD (n = 5). All the values were found to be significant
when compared to diabetic control at *P\ 0.05
Fig. 6 a Effect of oral administration of methanolic extract of S. nigrum and AgNPs on serum cholesterol. b Triglycerides level before and after
treatment. All the values were found to be significant with diabetic control at *P\ 0.05; **P\ 0.01; ***P\ 0.001
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under the curve which is significantly lesser than the dia-
betic control group, and these findings are in accordance
with previous research [36]. Figure 5 demonstrates the
level of changes in body weight of experimental rats at
before and after treatment. Weight loss is one of the major
syndrome associated with diabetes, probably due to muscle
wasting [37]. In our study the diabetic-induced rat group
(Group II) showed significant weight loss (Fig. 5) Com-
pared to group I (Normal control). The total cholesterol
(TC) and triglycerides (TG) levels were also elevated in
diabetic rats (Fig. 6a, b). It is well documented that DM
tends to reduce body weight as a result of increased muscle
wasting, dehydration, and fat catabolism. Whereas, the
treatment with plant extract as well as phytosynthesized
AgNPs significantly improved the body weight loss. The
TC and TG levels were retrieved comparable to normal
group over a period of 21 days administration of AgNPs,
the mechanism of preventing the muscle loss could prob-
ably attribute to reversal of antagonism [38].
Conclusion
In this present study, AgNPs were rapidly synthesized
using aqueous leaf extract of S. nigrum as a bio-reductant.
The efficacy of phytosynthesized AgNPs as an anti-hy-
perlipidemic agent has been evaluated. This study revealed
that the AgNPs are found to be safe and environmentally
friendly, hence, these AgNPs can be considered in treating
diabetes associated syndrome.
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